News from the FDA/CDC
News from the FDA/CDC
Children and COVID: New cases fell as the old year ended
Emergency department visits keep increasing as the pandemic’s death toll in children nears 2,000.
News from the FDA/CDC
CDC reports uptick in invasive Strep A infections
Consider this bacterial infection as a possible cause of severe illness in children and adults.
News from the FDA/CDC
Children and COVID: New-case counts offer dueling narratives
Data from the American Academy of Pediatrics appear to conflict with information provided by the Centers for Disease Control and Prevention.
News from the FDA/CDC
Children and COVID: Hospitalizations provide a tale of two sources
Thanksgiving travel seems to have had little effect on new pediatric cases.
Feature
U.S. flu activity already at mid-season levels
Nationally, 6% of all outpatient visits were because of flu or flu-like illness for the week of Nov. 13-19.
News from the FDA/CDC
Children and COVID: Weekly cases maintain a low-level plateau
White House coordinator says that a holiday COVID-19 surge is unlikely.
News from the FDA/CDC
FDA approves first-ever agent to delay type 1 diabetes onset
Teplizumab delayed progression to clinical type 1 diabetes by about 2 years compared with placebo in individuals destined to develop the condition...
News from the FDA/CDC
Children and COVID: Weekly cases continue to hold fairly steady
The latest hospital admission data may be telling a somewhat different story.
News from the FDA/CDC
Children and COVID: New cases increase for second straight week
Extended declines in ED visits and hospitalizations may be reversing.
News from the FDA/CDC
CDC warns of early uptick in respiratory disease
As influenza viruses, respiratory syncytial virus, SARS-CoV-2, and rhinovirus/enterovirus simultaneously circulate, the agency cautioned that this...
News from the FDA/CDC
FDA expands tenofovir alafenamide (Vemlidy) use to adolescents with chronic HBV
The study met its primary endpoint of percentage of patients with HBV DNA levels less than 20 IU/mL at 24 weeks of therapy.